drugset / Trial / NCT04613999
A Study of Ralinepag in Healthy Chinese Adult Subjects
NaSingle-groupOpen-labelTreatment
Summary
A Phase 1 Open-label, Non-randomized, Single Ascending Dose Escalation Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of A Ralinepag Extended Release (XR) Tablet Formulation In Healthy Chinese Subjects.
Timeline
- Start
- 2020-10-09
- Primary completion
- 2020-11-09
- Completion
- 2020-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ralinepag | Small molecule | 50 ug | Oral |
| Subject | Ralinepag | Small molecule | 100 ug | Oral |
| Subject | Ralinepag | Small molecule | 150 ug | Oral |
Indications
No indication recorded.